Fortis Group Advisors, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1815183
WESTWOOD, NJ
Position in TEVA
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$677
+$75 QoQ
Shares Held
20
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#661
of 671 holders
Holding Since
Sep 2020
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fortis Group Advisors, LLC holds $2,504,501 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (0.0% of the industry book) .
All Filings in TEVA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $677 | 20 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $602 | 20 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $624 | 20 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $404 | 20 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $335 | 20 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $307 | 20 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $440 | 20 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $360 | 20 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $325 | 20 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $282 | 20 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $416 | 40 | Shares | Sole | 2024-03-04 | |
| 2023-09-30 | $204 | 20 | Shares | Sole | 2023-12-01 | |
| 2020-09-30 | $180 | 20 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||